IP Library Granted Patent US 9,949,753
Granted Patent B2
US 9,949,753 · App. 13/828,231 · Granted Apr 24, 2018

Tissue slitting methods and systems

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,949,753
App. No.
13/828,231
Granted
Apr 24, 2018
Kind
B2
Abstract

Methods and systems for separating an object, such as a lead, from formed tissue are provided. Specifically, a tissue slitting device is configured to engage patient formed tissue at a slitting engagement point. While the object is subjected to a first traction force, the tissue slitting device is caused to move further into the engaged tissue and slit the tissue past the point of engagement. The slitting device causes the tissue to separate along an axial direction of the length of the formed tissue and releases at least some of the force containing the object. The methods and systems are well suited for use in cardiac pacing or defibrillator lead explant procedures.

Claims (19)

1. A tissue slitting apparatus comprising:

a shaft, wherein the shaft is flexible, the shaft having a proximal and a distal end, and wherein the shaft includes an inner lumen running from the proximal end to the distal end to receive at least one of an implanted object and mechanical traction device, and a central axis running along the inner lumen of the shaft; and

a laser member carried by the inner lumen of the shaft, the laser member comprising:

a plurality of optical fibers exposed adjacent to the distal end of the shaft, the plurality of optical fibers being aligned along only one direction perpendicular to the central axis of the shaft, wherein the plurality of optical fibers are configured to receive light energy from a laser light source and emit the light energy at the distal end in a distal direction; and

an engagement feature comprising a surface forming an arc extending less than 360 degrees, wherein the surface is configured to engage the at least one of the implanted object and the mechanical traction device, the surface disposed between the central axis of the shaft and the plurality of optical fibers.

2. A tissue slitting apparatus comprising:

a shaft, wherein the shaft is flexible, the shaft having a proximal and a distal end, and wherein the shaft includes an inner lumen running from the proximal end to the distal end to receive at least one of an implanted object and mechanical traction device, and a central axis running along the inner lumen of the shaft, and wherein the distal end comprises a wall disposed radially outwardly relative to the inner lumen; and

a laser member carried by the inner lumen of the shaft, the laser member comprising:

a plurality of optical fibers exposed adjacent to the distal end of the shaft, the plurality of optical fibers being aligned along only one radial direction perpendicular to the central axis of the shaft, wherein one of the plurality of optical fibers is disposed radially outwardly of the wall at the distal end, and another one of the plurality of optical fibers is disposed radially inwardly of the wall at the distal end, wherein the plurality of optical fibers are configured to receive light energy from a laser light source and emit the light energy at the distal end in a distal direction; and

an engagement feature comprising an arcuate surface, wherein the arcuate surface is configured to engage the at least one of the implanted object and the mechanical traction device, the arcuate surface disposed between the central axis of the shaft and the plurality of optical fibers.

3. The tissue slitting apparatus of claim 2 , further comprising the laser light source.

4. The tissue slitting apparatus of claim 3 , wherein the laser light source is configured to output one or more wavelengths of laser light.

5. The tissue slitting apparatus of claim 3 , wherein the laser light source is an XeCl Excimer laser and the light energy has a wavelength of 308 nm.

6. The tissue slitting apparatus of claim 3 , further comprising a second laser light source configured to generate light energy, wherein the light energy generated by the second laser light source has a wavelength other than 308 nm.

7. The tissue slitting apparatus of claim 3 , further comprising at least one optical component disposed between the plurality of optical fibers and the laser light source, wherein the at least one optical component is configured to alter a characteristic associated with the light energy.

8. The tissue slitting apparatus of claim 7 , wherein the at least one optical component is one or more of a filter, lens, prism, coating, film, and deposited layer of optically transmissive material.

9. The tissue slitting apparatus of claim 3 , wherein the tissue slitting apparatus is configured to subject a tissue growth to a slitting action only about a partial periphery of an internal diameter of the tissue growth adjacent to and at least substantially surrounding the implanted object at any point along the implanted object.

10. The tissue slitting apparatus of claim 3 , wherein each of the plurality of optical fibers comprises a terminating end, wherein the terminating end of the plurality of optical fibers are disposed to emit light energy at an angle relative to the central axis of the shaft.

11. The tissue slitting apparatus of claim 3 , wherein each of the plurality of optical fibers comprises a terminating end, wherein the terminating end of the plurality of optical fibers are disposed to emit light energy parallel to the central axis of the shaft.

Assignments (8)
RELEASE OF SECURITY INTEREST Recorded Aug 10, 2017
From: MIDCAP FINANCIAL TRUST
To: THE SPECTRANETICS CORPORATION; ANGIOSCORE INC.
Reel/Frame 043518/0066 →
RELEASE OF SECURITY INTEREST Recorded Aug 10, 2017
From: MIDCAP FINANCIAL TRUST
To: THE SPECTRANETICS CORPORATION; ANGIOSCORE INC.
Reel/Frame 043518/0142 →
RELEASE OF SECURITY INTEREST Recorded Dec 11, 2015
From: WELLS FARGO BANK, NATIONAL ASSOCIATION
To: THE SPECTRANETICS CORPORATION
Reel/Frame 037268/0793 →
SECURITY INTEREST (REVOLVER) Recorded Dec 11, 2015
From: THE SPECTRANETICS CORPORATION
To: MIDCAP FINANCIAL TRUST, AS AGENT
Reel/Frame 037269/0425 →
SECURITY INTEREST (TERM) Recorded Dec 11, 2015
From: THE SPECTRANETICS CORPORATION
To: MIDCAP FINANCIAL TRUST, AS AGENT
Reel/Frame 037269/0506 →
SECURITY INTEREST Recorded Jul 2, 2015
From: THE SPECTRANETICS CORPORATION
To: WELLS FARGO BANK, NATIONAL ASSOCIATION
Reel/Frame 036055/0156 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 15, 2013
From: BOWE, WADE A.; BURTON, GEORGE WOODROW; DALBY, PAUL JOSEPH; SOTAK, RYAN MICHAEL
To: THE SPECTRANETICS CORPORATION
Reel/Frame 030214/0491 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 15, 2013
From: BOWE, WADE A.; BURTON, GEORGE WOODROW; DALBY, PAUL JOSEPH; SOTAK, RYAN MICHAEL
To: THE SPECTRANETICS CORPORATION
Reel/Frame 030216/0200 →